Deora simplifies dose administration with a pull-push mechanism: users pull to set the dose and push to inject.

(Corrects paragraph 2 to say Hympavzi is the first non-factor therapy particularly for pediatric patients with hemophilia B, ...

The new expansion covers all patients 6 and older, regardless of their inhibitor status. The new nod also opens up the ...

Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy ...

Domestic brokerage firms continue to remain positive on Shaily Engineering Plastics, one of the stocks from Ashish Kacholia's ...

Raoul secures $8.25 million Mylan settlement over EpiPen anticompetitive practices affecting Illinois Medicaid and state ...

SAO PAULO, May 26 (Reuters) - Brazil's health regulator Anvisa said on Tuesday it had approved EMS's Ozivy, the country's first semaglutide-based ‌injector pen, as the drugmaker looks to expand into a ...

Shaily Engineering Plastics announced that its strategic partner Orbicular Pharmaceutical Technologies in partnership with its Customer has launched a generic version of Semaglutide injection in ...

Dr Reddy's Laboratories on Saturday said it has launched its generic version of Semaglutide injection used in treatment of type 2 diabetes in Canada. The company is among the first firms to introduce ...

Once-monthly, third-generation PCSK9 inhibitor now available with direct-to-patient cash-pay option at $199 per month, a substantial discount to other PCSK9 inhibitors direct-to-patient cash prices1,2 ...